Loading …
Never Run Out Of Buyers To Sell To.

12-15 Molecular Diagnostics is in the business of developing a Point of Care, Rapid Response Diagnostic Device for detecting and differentiating between Bacterial & Viral Infections using Biofluids.
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.